Early Pfizer data has shown the vaccine — which is administered to younger kids at one-tenth the strength of the adult shot — is safe and produces an immune response.
But last year Pfizer announced the two-dose shot proved to be less effective at preventing COVID-19 in kids ages 2-5, and regulators encouraged the company to add a third dose to the study on the belief that another dose would boost the vaccine’s effectiveness much like booster doses do in adults.
The person spoke on the condition of anonymity to discuss sensitive regulatory issues. The person said the decreased effectiveness of the two-dose vaccine was not unexpected given the emergence of the highly transmissible omicron variant of COVID-19. Allowing young kids to be vaccinated with a two-dose shot earlier would ultimately accelerate when they could get the expected stronger protection from a third dose.
Young children are far less likely than adults to develop serious complications or to die from COVID-19, but incidences of illness among the age group have risen amid the nationwide spike in cases from the omicron variant. Most cases and deaths occur among older people, especially those who are unvaccinated.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
US urges Pfizer to apply for COVID vaccine shots for kids under 5U.S. regulators are urging Pfizer to apply for emergency authorization for its COVID-19 vaccine for children 6 months to 5 years old, aiming to clear the way for the shots as soon as late February.
続きを読む »
AP source: US urges Pfizer to apply for under-5 COVID shotsWASHINGTON (AP) — U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for...
続きを読む »
AP source: US urges Pfizer to apply for under-5 COVID shotsRegulators are urging Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months-5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February.
続きを読む »
US Urges Pfizer to Apply for Under-5 COVID Shots: AP SourceU.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old
続きを読む »
Pfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayChildren as young as 6 months old could be eligible for the COVID-19 vaccine later this month.
続きを読む »
Pfizer expected to ask for authorization of under-5 COVID shots as soon as TuesdayChildren as young as 6 months old could be eligible for the COVID-19 vaccine later this month.
続きを読む »